Total raised in public, private and other financings of biopharma companies, comparing 2019-2025.

A preview of the next edition of BioWorld, Oct. 27, 2025

Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: GSK, Johnson & Johnson, Partner, Ribocure, Suzhou Ribo, Sydnexi.

Biopharma happenings, including deals and partnerships, and other news in brief: Biossil, Chugai, Elevara, Maruho, Medivir, Mitocarex, Nanobiotix, Nielsen, Renalys, Scisparc, Secarna, Scenic, Teijin.

Clinical updates, including data readouts and publications: Aprea, Arcutis, Armata, Ascletis, Dicot, Eli Lilly, Entera, George Medicines, Hanchorbio, Harbour, Incyte, Inhibrx, Johnson & Johnson, Journey Medical, Metis, Moderna, Revolution, Sagimet, Silver Creek, Spinogenix, Ventyx, Verastem, Zai Lab, Zymeworks.

Biopharmas raising money in public or private financings, including: Coya, Grace, Rani, X4.

New hires and promotions in the biopharma industry, including: Rani.

The top 10 biopharma stock gainers and losers for the week.

A quick look back at top stories.